Hello, Guest!
  • Saturday, December 21, 2024

AstraZeneca Receives $205M Army COVID-19 Antibody Drug Order

The U.S. Army has reserved at least 100,000 doses of AstraZeneca’s AZD7442, a long-acting antibody product designed to prevent COVID-19 infection or treat the coronavirus disease, through a $204.9 million contract modification.

The service branch obligated the full amount using its fiscal 2021 research, development, test and evaluation funds, the Department of Defense said Tuesday.

Contract work will take place in Wilmington, Delaware, through Dec. 31.

AstraZeneca licensed the AZD7442 combination therapy of two long-acting antibodies from the Vanderbilt University Medical Center in Nashville, Tennessee, last year and engineered the drug using the company’s proprietary half-life extension technology.

A Phase III clinical trial is underway to evaluate the efficacy and safety of the LAAB combo product as a treatment for non-hospitalized COVID-19 patients.

Video of the Day

Related Articles

Navy Awards 8 Companies Spots on $701M Ship Maintenance IDIQ Contract Awards

Navy Awards 8 Companies Spots on $701M Ship Maintenance IDIQ

Eight companies have won spots on a five-year, $701 million indefinite-delivery/indefinite-quantity contract from the U.S. Navy to repair, maintain and modernize non-nuclear surface ships homeported in Mayport, Florida. The contractors will conduct continuous maintenance emergent maintenance of the ship and provide short-term support to the Chief of Naval Operations, the Department of Defense said Wednesday.

Air Force Posts Solicitation for Potential $5.7B Combat Air Force Support Follow-On Contract News

Air Force Posts Solicitation for Potential $5.7B Combat Air Force Support Follow-On Contract

The U.S. Air Force has begun seeking proposals for a potential $5.7 billion follow-on multiple-award contract to provide combat air forces contracted air support services to help protect U.S. assets against advanced airborne threats. CAF CAS II seeks to procure non-personal services for realistic advanced adversary air threats and close air support threats to support

Northrop Lands $167M Navy Contract Modification for G/ATOR Radar Tech Contract Awards

Northrop Lands $167M Navy Contract Modification for G/ATOR Radar Tech

Northrop Grumman (NYSE: NOC) has secured a potential $167.1 million contract modification from the U.S. Navy to supply four lot 6 full-rate production Ground/Air Task Oriented Radar systems. Marine Corps Systems Command is the contracting activity and will obligate the full contract amount using the U.S. Air Force’s other procurement funds for fiscal year 2024,